Clinical trial
Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke, a Randomized Controlled Trial
NCT06120725 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke, a Randomized Controlled Trial
- Lead sponsor
- Kafrelsheikh University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 1, 2021
- Completion date
- November 1, 2023
- Enrollment
- 580 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.